NASH Network (NASHNET), a global network of thought leaders dedicated to advancing care pathways for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), has published a novel cost-effectiveness analysis (CEA)
During the COVID-19 pandemic and beyond, it will be critical for clinicians to help reverse the nation’s liver disease epidemic through early detection and monitoring of NAFLD/NASH and support lifestyle management programs.
“What was really sad for me as a physician was when the poor patient was in the position of having to choose between his health and making a living.” said Larry Wofe, retired Medical Doctor. Jon Slaughter, CEO of Healthy Trucking of America says, “Obesity is the gateway to more severe chronic diseases. Becoming symptomatic to Type 2 Diabetes can be reversed, however a sedentary and stressful profession like trucking doesn’t help.”
Nasal stents could be a promising solution for the estimated one-third of truckers with sleep apnea, which can create major fatigue-related safety issues on the road.
Liver disease has been inextricably linked to metabolic syndrome (MetS) and obesity and may result from work-related conditions that include long hours on the road with limited opportunities for physical activity, healthy food and regular shift and sleep patterns.
The next time you get a shipment of toilet paper from Amazon, or a knickknack from Etsy, or even a letter from your Aunt Sue in Tuscaloosa, thank a trucker. According to one